Impact of oral nutritional supplements in post-discharge patients at nutritional risk after surgery for colorectal cancer: A randomised clinical trial

ABSTRACT: Interventions: ONS group:patients received dietary advice and oral intake of Nutren Optimum (Nestle Health Science, Switzerland) at a dosage of 500 mL daily for 3 months after discharge as a supplement to regular meals;Control group:patients received dietary advice alone, which was identical to those for ONS group Primary outcome(s): Nutritional outcomes;Sarcopenia prevalence Study Design: Parallel

DISEASE(S): Colorectal Cancer

PROVIDER: 2690037 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR